From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications
International Health Sciences Review · 20.04.2026 · 2 (2)
DOI: 10.70164/ihsr.v2i2.157 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 20.04.2026. Verfasst von Verena Coelho Lobão Azevedo und 16 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition influenced by complex interactions between genetic and epigenetic factors, resulting in diverse phenotypic manifestations. The identification of molecular biomarkers has emerged as a promising approach to improve diagnosis and clinical management. Methodology: This integrative literature review was conducted using PubMed, SciELO, LILACS, MEDLINE, and Google Scholar, including studies published between 2021 and 2025 in English, Portuguese, and Spanish. Eligible studies addressed genetic and/or epigenetic biomarkers in ASD and their clinical applications. Results and Discussion: Seventeen studies were included. Evidence indicates that ASD involves both rare genetic variants and polygenic risk. Epigenetic mechanisms, such as DNA methylation and microRNAs, contribute to gene expression regulation and phenotype modulation. The integration of multi-omics data has improved biomarker identification, although challenges in validation remain.
Conclusion
Genetic and epigenetic biomarkers demonstrate potential for early diagnosis and personalized approaches in ASD; however, further studies are needed to ensure their clinical applicability.
Zitieren
APA
Azevedo, V. C. L., Florêncio, M. G. D. R., Sarquis, S. P. B. G., Lage, L. S., Lobato, M. H. M. C., Brito, N. C. D., Dias, R. A., Silva, P. J. M. D., Neves, B. C. F., Scarparo, E. B. T., Araújo, L. R. D., Neto, P. J. M. D. S., Rocha, M. B. F. D., Miranda, R. S., Moriya, M. D. A., Araújo, J. R. D., & Guimarães, M. C. M. (2026). From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications. International Health Sciences Review, 2(2). https://doi.org/10.70164/ihsr.v2i2.157
Vancouver
Azevedo VCL, Florêncio MGDR, Sarquis SPBG, Lage LS, Lobato MHMC, Brito NCD, et al. From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications. International Health Sciences Review. 2026;2(2). doi:10.70164/ihsr.v2i2.157
BibTeX
@article{Azevedo2026,
author = {Azevedo, Verena Coelho Lobão and Florêncio, Maria Gabriela da Rocha and Sarquis, Samarina Pompeu Braga Gonçalves and Lage, Luana Serra and Lobato, Marília Helena Melo Carralas and Brito, Nalinny Coelho de and Dias, Renata Alves and Silva, Paula Jordana Maia da and Neves, Bernard Cainã Ferreira and Scarparo, Edge Biffi Teixeira and Araújo, Luciana Rodrigues de and Neto, Paulo José Marques de Sousa and Rocha, Mário Bernardo Farias da and Miranda, Rebeca Silva and Moriya, Marjorie de Almeida and Araújo, Juliana Rodrigues de and Guimarães, Márcia Cristina Monteiro},
title = {From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications},
journal = {International Health Sciences Review},
year = {2026},
volume = {2},
number = {2},
doi = {10.70164/ihsr.v2i2.157}
}
EUVIMED